OVIT OTC
OncoVista Innovative Therapies, Inc.
1W: +0.0%
1M: +0.0%
3M: -0.0%
YTD: -75.0%
1Y: +0.0%
3Y: -93.3%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$3M
-67.2% ▼
Net Income
-$3M
-75.5% ▼
EPS (Diluted)
$-0.12
-71.4% ▼
EBITDA
-$3M
-67.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $451K | $1M | $1M | $901K | $669K |
| SG&A Expenses | $2M | $1M | $881K | $622K | $2M |
| Operating Expenses | $2M | $2M | $2M | $2M | $3M |
| Operating Income | -$2M | -$2M | -$2M | -$2M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $147K | $24K | $7K | $152 | $8K |
| Income Before Tax | $0 | -$2M | -$2M | -$1M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $10M | -$2M | -$2M | -$1M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.11 | $-0.10 | $-0.08 | $-0.07 | $-0.12 |
| EBITDA | -$2M | -$2M | -$2M | -$2M | -$3M |
| Shares Outstanding | 20M | 21M | 22M | 22M | 22M |